mTOR activation was significantly reduced when LNA-anti-miR-301a was introduced into IPF fibroblasts, whereas concomitant TSC1 knockdown reversed the status of mTOR activation (Figure 5L). Here, TSC1 is linked to idiopathic pulmonary fibrosis.